| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 National Korányi Institute for Pulmonology, Budapest, Hungary. 2 Division of Pediatric Respiratory Medicine, University of Virginia, Charlottesville, VA, USA. 3 National Heart & Lung Institute, Imperial College, London, UK.
CORRESPONDENCE: I. Horváth, National Korányi Institute for Pulmonology, Dept of Pathophysiology, Budapest PO Box 1, Piheno u. 1. H-1529, Hungary. Fax: 36 13943521. E-mail: hildiko@koranyi.hu
Keywords: Airway inflammation, biomarkers, exhaled breath condensate, lung diseases, noninvasive monitoring, oxidative stress
Received: March 14, 2005
Accepted April 28, 2005
Collection of exhaled breath condensate (EBC) is a noninvasive method for obtaining samples from the lungs. EBC contains large number of mediators including adenosine, ammonia, hydrogen peroxide, isoprostanes, leukotrienes, nitrogen oxides, peptides and cytokines. Concentrations of these mediators are influenced by lung diseases and modulated by therapeutic interventions. Similarly EBC pH also changes in respiratory diseases.
The aim of the American Thoracic Society/European Respiratory Society Task Force on EBC was to identify the important methodological issues surrounding EBC collection and assay, to provide recommendations for the measurements and to highlight areas where further research is required.
Based on the currently available evidence and the consensus of the expert panel for EBC collection, the following general recommendations were put together for oral sample collection: collect during tidal breathing using a noseclip and a saliva trap; define cooling temperature and collection time (10 min is generally sufficient to obtain 1–2 mL of sample and well tolerated by patients); use inert material for condenser; do not use resistor and do not use filter between the subject and the condenser. These are only general recommendations and certain circumstances may dictate variation from them.
Important areas for future research involve: ascertaining mechanisms and site of exhaled breath condensate particle formation; determination of dilution markers; improving reproducibility; employment of EBC in longitudinal studies; and determining the utility of exhaled breath condensate measures for the management of individual patients. These studies are required before recommending this technique for use in clinical practice.
This article has been cited by other articles:
|
|
 |
|
  P. P. Rosias, C. M. Robroeks, A. Kester, G. J. den Hartog, W. K. Wodzig, G. T. Rijkers, L. J. Zimmermann, C. P. van Schayck, Q. Jobsis, and E. Dompeling Biomarker reproducibility in exhaled breath condensate collected with different condensers Eur. Respir. J., May 1, 2008; 31(5): 934 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Bayley, H. Abusriwil, A. Ahmad, and R. A. Stockley Validation of assays for inflammatory mediators in exhaled breath condensate Eur. Respir. J., May 1, 2008; 31(5): 943 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. R. Rosias, Q. Jobsis, K. van de Kant, C. Robroeks, C. P. van Schayck, L. J. I. Zimmermann, and E. Dompeling Global condensation: a "climate change" towards better standardisation of exhaled breath condensate measurements Eur. Respir. J., March 1, 2008; 31(3): 684 - 685. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pugin, I. Dunn-Siegrist, J. Dufour, P. Tissieres, P.-E. Charles, and R. Comte Cyclic Stretch of Human Lung Cells Induces an Acidification and Promotes Bacterial Growth Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 362 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Hoffmann, L. M. Tabaksblat, J. J. Enghild, and R. Dahl Human skin keratins are the major proteins in exhaled breath condensate Eur. Respir. J., February 1, 2008; 31(2): 380 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kullmann, I. Barta, B. Antus, M. Valyon, and I. Horvath Environmental temperature and relative humidity influence exhaled breath condensate pH Eur. Respir. J., February 1, 2008; 31(2): 474 - 475. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Carraro, C. Guillou, F. Reniero, G. Giordano, and E. Baraldi Metabolomics in Exhaled Breath Condensates Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 236 - 236. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Montuschi Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 5 - 23. [Abstract] [PDF]
|
|
|
|
|
|
B. Balbi, P. Pignatti, M. Corradi, P. Baiardi, L. Bianchi, G. Brunetti, A. Radaeli, G. Moscato, A. Mutti, A. Spanevello, et al. Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults Eur. Respir. J., October 1, 2007; 30(4): 769 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Piotrowski, A. Antczak, J. Marczak, A. Nawrocka, Z. Kurmanowska, and P. Gorski Eicosanoids in Exhaled Breath Condensate and BAL Fluid of Patients With Sarcoidosis Chest, August 1, 2007; 132(2): 589 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Horvath From the authors Eur. Respir. J., July 1, 2007; 30(1): 187 - 187. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lehtonen, P. Oksa, L. Lehtimaki, A. Sepponen, R. Nieminen, H. Kankaanranta, S. Saarelainen, R. Jarvenpaa, J. Uitti, and E. Moilanen Increased alveolar nitric oxide concentration and high levels of leukotriene B4 and 8-isoprostane in exhaled breath condensate in patients with asbestosis Thorax, July 1, 2007; 62(7): 602 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Celli and P. J. Barnes Exacerbations of chronic obstructive pulmonary disease Eur. Respir. J., June 1, 2007; 29(6): 1224 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Corhay, L. Hemelaers, M. Henket, J. Sele, and R. Louis Granulocyte Chemotactic Activity in Exhaled Breath Condensate of Healthy Subjects and Patients With COPD Chest, June 1, 2007; 131(6): 1672 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hunt If It Smells Like a Duck, It Might Be an Asthma Subphenotype Am. J. Respir. Crit. Care Med., May 15, 2007; 175(10): 975 - 976. [Full Text] [PDF]
|
|
|
|
|
|
S. Carraro, S. Rezzi, F. Reniero, K. Heberger, G. Giordano, S. Zanconato, C. Guillou, and E. Baraldi Metabolomics Applied to Exhaled Breath Condensate in Childhood Asthma Am. J. Respir. Crit. Care Med., May 15, 2007; 175(10): 986 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Baker, N. Clark, A. L. Brennan, D. A. Fisher, K. M. Gyi, M. E. Hodson, B. J. Philips, D. L. Baines, and D. M. Wood Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis J Appl Physiol, May 1, 2007; 102(5): 1969 - 1975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bergeron, M. K. Tulic, and Q. Hamid Tools used to measure airway remodelling in research Eur. Respir. J., March 1, 2007; 29(3): 596 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kullmann, I. Barta, Z. Lazar, B. Szili, E. Barat, M. Valyon, M. Kollai, and I. Horvath Exhaled breath condensate pH standardised for CO2 partial pressure Eur. Respir. J., March 1, 2007; 29(3): 496 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Jackson, A. Sandrini, C. Campbell, S. Chow, P. S. Thomas, and D. H. Yates Comparison of Biomarkers in Exhaled Breath Condensate and Bronchoalveolar Lavage Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 222 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. Kinnula, H. Ilumets, M. Myllarniemi, A. Sovijarvi, and P. Rytila 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD Eur. Respir. J., January 1, 2007; 29(1): 51 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Carraro Noninvasive markers of airway inflammation and redox biochemistry applied to asthma Eur. Respir. Rev., December 1, 2006; 15(101): 202 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gaber, F. Acevedo, I. Delin, B-M. Sundblad, L. Palmberg, K. Larsson, M. Kumlin, and S-E. Dahlen Saliva is one likely source of leukotriene B4 in exhaled breath condensate Eur. Respir. J., December 1, 2006; 28(6): 1229 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Birrell, K. McCluskie, E. Hardaker, R. Knowles, and M. G. Belvisi Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model Eur. Respir. J., December 1, 2006; 28(6): 1236 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Rosias, C. M. Robroeks, H. J. Niemarkt, A. D. Kester, J. H. Vernooy, J. Suykerbuyk, J. Teunissen, J. Heynens, H. J. Hendriks, Q. Jobsis, et al. Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate Eur. Respir. J., November 1, 2006; 28(5): 1036 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Muller, F. Morini, S. Eaton, M. Peters, and A. Jaffe Safety and feasibility of exhaled breath condensate collection in ventilated infants and children Eur. Respir. J., September 1, 2006; 28(3): 479 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Nicolaou, L. A. Lowe, C. S. Murray, A. Woodcock, A. Simpson, and A. Custovic Exhaled Breath Condensate pH and Childhood Asthma: Unselected Birth Cohort Study Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 254 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. L. Borrill, J. A. Smith, J. Naylor, A. A. Woodcock, and D. Singh The effect of gas standardisation on exhaled breath condensate pH. Eur. Respir. J., July 1, 2006; 28(1): 251 - 252. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mutti, M. Corradi, M. Goldoni, M. V. Vettori, A. Bernard, and P. Apostoli Exhaled Metallic Elements and Serum Pneumoproteins in Asymptomatic Smokers and Patients With COPD or Asthma Chest, May 1, 2006; 129(5): 1288 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 ATS Workshop Proceedings: Exhaled Nitric Oxide and Nitric Oxide Oxidative Metabolism in Exhaled Breath Condensate. Proceedings of the ATS, January 1, 2006; 3(2): 131 - 145. [Full Text] [PDF]
|
|
|
|
|
|
O. Holz Catching breath: monitoring airway inflammation using exhaled breath condensate Eur. Respir. J., September 1, 2005; 26(3): 371 - 372. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
